Retraction: MicroRNA-148a inhibits the proliferation and promotes the paclitaxel-induced apoptosis of ovarian cancer cells by targeting PDIA3 (Molecular Medicine Reports (2015) 12 (3923-3929) DOI: 10.3892/mmr.2015.3826);MicroRNA-148a inhibits the proliferation and promotes the paclitaxel-induced apoptosis of ovarian cancer cells by targeting PDIA3

Molecular Medicine Reports

Volumn 12, Issue 3, 2015, Pages 3923-3929

  Zhao, Shuzhen ^a   Wen, Zhengfang ^a   Liu, Shanshan ^a   Liu, Ying ^a   Li, Xiaorui ^a   Ge, Yanna ^a   Li, Shaoru ^a  

^a XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Member 3; microRNA 148a; Ovarian cancer; Paclitaxel; Protein disulfide isomerase family A

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 148A; PACLITAXEL; PROTEIN DISULFIDE ISOMERASE; PROTEIN DISULFIDE ISOMERASE FAMILY A MEMBER 3; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; ANTINEOPLASTIC AGENT; MIRN148 MICRORNA, HUMAN; PDIA3 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; AGED; APOPTOSIS; APOPTOSIS ASSAY; ARTICLE; BIOINFORMATICS; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUCIFERASE ASSAY; OVARIAN CANCER CELL LINE; OVARY CANCER; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA BINDING; UPREGULATION; WESTERN BLOTTING; BINDING SITE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; OVARIAN NEOPLASMS; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; OVARIAN NEOPLASMS; PACLITAXEL; PROTEIN DISULFIDE-ISOMERASES; RNA INTERFERENCE;

EID: 84935440073     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2021.12294     Document Type: Erratum

References (25)

1. Choi JH, Wong AS, Huang HF and Leung PC: Gonadotropins and ovarian cancer. Endocr Rev 28:440-461, 2007.
2. Shylasree TS, Bryant A and Athavale R: Chemotherapy and/or radiotherapy in combination with surgery for ovarian carcinosarcoma. Cochrane Database Syst Rev 2:CD006246, 2013.
3. Llauradó M, Majem B, Altadill T, et al: MicroRNAs as prognostic markers in ovarian cancer. Mol Cell Endocrinol 390:73-84, 2014.
4. Park SH, Song JY, Kim YK, et al: Fascin1 expression in high-grade serous ovarian carcinoma is a prognostic marker and knockdown of fascin1 suppresses the proliferation of ovarian cancer cells. Int J Oncol 44:637-646, 2014.
5. Ambros V: The functions of animal microRNAs. Nature 431:350-355, 2004.
6. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism and function. Cell 116:281-297, 2004.
7. Bienertova-Vasku J, Sana J and Slaby O: The role of microRNAs in mitochondria in cancer. Cancer Lett 336:1-7, 2013.
8. Li J, Song Y, Wang Y, Luo J and Yu W: MicroRNA-148a suppresses epithelial-to-mesenchymal transition by targeting ROCK1 in non-small cell lung cancer cells. Mol Cell Biochem 380:277-282, 2013.
9. Heo MJ, Kim YM, Koo JH, et al: microRNA-148a dysregulation discriminates poor prognosis of hepatocellular carcinoma in association with USP4 overexpression. Oncotarget 5:2792-2806, 2014.
10. Zheng B, Liang L, Wang C, et al: MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer. Clin Cancer Res 17:7574-7583, 2011.
11. Zhang J P, Zeng C, Xu L, Gong J, Fang JH and Zhuang SM: MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling. Oncogene 33:4069-4076, 2014.
12. Zhou X, Zhao F, Wang ZN, et al: Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation. Oncol Rep 27:447-454, 2012.
13. Hou F, Wang L, Wang H, et al: Elevated gene expression of S100A12 is correlated with the predominant clinical inflammatory factors in patients with bacterial pneumonia. Mol Med Rep 11:4345-4352, 2015.
14. Chay D, Cho H, Lim BJ, et al: ER-60 (PDIA3) is highly expressed in a newly established serous ovarian cancer cell line, YDOV-139. Int J Oncol 37:399-412, 2010.
15. Ménoret A, Drew DA, Miyamoto S, et al: Differential proteomics identifies PDIA3 as a novel chemoprevention target in human colon cancer cells. Mol Carcinog 53(Suppl 1):E11-E22, 2014.
16. Murata T, Takayama K, Katayama S, et al: miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression. Prostate Cancer Prostatic Dis 13:356-361, 2010.
17. Xia J, Guo X, Yan J and Deng K: The role of miR-148a in gastric cancer. J Cancer Res Clin Oncol 140:1451-1456, 2014.
18. Long XR, He Y, Huang C and Li J: MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in hepatocellular carcinogenesis. Int J Oncol 44:1915-1922, 2014.
19. Fujita Y, Kojima K, Ohhashi R, et al: MiR-148a attenuates paclitaxel resistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression. J Biol Chem 285:19076-19084, 2010.
20. Turano C, Gaucci E, Grillo C and Chichiarelli S: ERp57/GRP58: A protein with multiple functions. Cell Mol Biol Lett 16:539-563, 2011.
21. Chung H, Cho H, Perry C, et al: Downregulation of ERp57 expression is associated with poor prognosis in early-stage cervical cancer. Biomarkers 18:573-579, 2013.
22. Gaucci E, Altieri F, Turano C and Chichiarelli S: The protein ERp57 contributes to EGF receptor signaling and internalization in MDA-MB-468 breast cancer cells. J Cell Biochem 114:2461-2470, 2013.
23. Cicchillitti L, Di Michele M, Urbani A, et al: Comparative proteomic analysis of paclitaxel sensitive A2780 epithelial ovarian cancer cell line and its resistant counterpart A2780TC1 by 2D-DIGE: The role of ERp57. J Proteome Res 8:1902-1912, 2009.
24. 1/S arrest in breast cancer cells in vitro. Anat Rec (Hoboken) 295:410-416, 2012.
25. Cicchillitti L, Della Corte A, Di Michele M, Donati MB, Rotilio D and Scambia G: Characterisation of a multimeric protein complex associated with ERp57 within the nucleus in paclitaxel-sensitive and -resistant epithelial ovarian cancer cells: The involvement of specific conformational states of beta-actin. Int J Oncol 37:445-454, 2010.